pubmed-article:9416379 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C0019693 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C0043474 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C0010181 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C0016884 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C1561577 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C1519031 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C0205344 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C0042295 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C1514811 | lld:lifeskim |
pubmed-article:9416379 | lifeskim:mentions | umls-concept:C1706462 | lld:lifeskim |
pubmed-article:9416379 | pubmed:issue | 12 | lld:pubmed |
pubmed-article:9416379 | pubmed:dateCreated | 1998-2-2 | lld:pubmed |
pubmed-article:9416379 | pubmed:abstractText | This study was undertaken to evaluate the cost and the effectiveness of zidovudine monotherapy in patients with advanced HIV infection and to derive preliminary data on the cost-effectiveness of the triple treatment with saquinavir plus zalcitabine plus zidovudine compared with zidovudine alone. | lld:pubmed |
pubmed-article:9416379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9416379 | pubmed:language | eng | lld:pubmed |
pubmed-article:9416379 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9416379 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9416379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9416379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9416379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9416379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9416379 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9416379 | pubmed:month | Dec | lld:pubmed |
pubmed-article:9416379 | pubmed:issn | 1060-0280 | lld:pubmed |
pubmed-article:9416379 | pubmed:author | pubmed-author:MartiniNN | lld:pubmed |
pubmed-article:9416379 | pubmed:author | pubmed-author:FontMM | lld:pubmed |
pubmed-article:9416379 | pubmed:author | pubmed-author:MessoriAA | lld:pubmed |
pubmed-article:9416379 | pubmed:author | pubmed-author:TosoliniFF | lld:pubmed |
pubmed-article:9416379 | pubmed:author | pubmed-author:BecagliPP | lld:pubmed |
pubmed-article:9416379 | pubmed:author | pubmed-author:VenturiniFF | lld:pubmed |
pubmed-article:9416379 | pubmed:author | pubmed-author:TrippoliSS | lld:pubmed |
pubmed-article:9416379 | pubmed:author | pubmed-author:BertoVV | lld:pubmed |
pubmed-article:9416379 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9416379 | pubmed:volume | 31 | lld:pubmed |
pubmed-article:9416379 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9416379 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9416379 | pubmed:pagination | 1447-54 | lld:pubmed |
pubmed-article:9416379 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:9416379 | pubmed:meshHeading | pubmed-meshheading:9416379-... | lld:pubmed |
pubmed-article:9416379 | pubmed:meshHeading | pubmed-meshheading:9416379-... | lld:pubmed |
pubmed-article:9416379 | pubmed:meshHeading | pubmed-meshheading:9416379-... | lld:pubmed |
pubmed-article:9416379 | pubmed:meshHeading | pubmed-meshheading:9416379-... | lld:pubmed |
pubmed-article:9416379 | pubmed:meshHeading | pubmed-meshheading:9416379-... | lld:pubmed |
pubmed-article:9416379 | pubmed:meshHeading | pubmed-meshheading:9416379-... | lld:pubmed |
pubmed-article:9416379 | pubmed:meshHeading | pubmed-meshheading:9416379-... | lld:pubmed |
pubmed-article:9416379 | pubmed:meshHeading | pubmed-meshheading:9416379-... | lld:pubmed |
pubmed-article:9416379 | pubmed:meshHeading | pubmed-meshheading:9416379-... | lld:pubmed |
pubmed-article:9416379 | pubmed:meshHeading | pubmed-meshheading:9416379-... | lld:pubmed |
pubmed-article:9416379 | pubmed:meshHeading | pubmed-meshheading:9416379-... | lld:pubmed |
pubmed-article:9416379 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9416379 | pubmed:articleTitle | Advanced HIV infection treated with zidovudine monotherapy: lifetime values of absolute cost-effectiveness as a pharmacoeconomic reference for future studies evaluating antiretroviral combination treatments. The Osservatorio SIFO sui Farmaci. | lld:pubmed |
pubmed-article:9416379 | pubmed:affiliation | Drug Information Center, Azienda Ospedaliera Careggi, Firenze, Italy. md3439@mclink.it | lld:pubmed |
pubmed-article:9416379 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9416379 | pubmed:publicationType | Comparative Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9416379 | lld:pubmed |